Inactive Instrument

Highlights Pangaea Oncology, S.A. BME

Equities

Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	05-08	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-30	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-27	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-28	CI
Vidaro Inversiones S.L. acquired 6.62% stake in Pangaea Oncology, S.A. from HERSOL XXI, SL for €1.5 million.	20-10-12	CI
HERSOL XXI, SL acquired an additional 0.6% stake in Pangaea Oncology, S.A. from director of Grupo Pikolin, S.L. for €0.15 million.	18-01-02	CI
GrupoPikolin, S.L. acquired 24.94% stake in Pangaea Oncology, S.A. from Mercantile Ebrosol Inversiones, S.L.U.	17-01-02	CI

No results for this search